MTAP immunohistochemistry as a surrogate marker of CDKN2A loss in brain tumors: A meta-analysis and literature review. Dono A, Pichardo-Rojas D, Mendoza Mora L, Pichardo-Rojas PS, et al. J Neuropathol Exp Neurol 2025 Apr 18:nlaf033. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Dono A, Pichardo-Rojas D, Mendoza Mora L, Pichardo-Rojas PS, et al. MTAP immunohistochemistry as a surrogate marker of CDKN2A loss in brain tumors: A meta-analysis and literature review. J Neuropathol Exp Neurol 2025 Apr 18:nlaf033. doi: 10.1093.
PMID: 40249413